|
2 Companies |
|
3 Products |
|
3 Products |
|
3 Mechanisms of Action |
|
0 Trials |
|
35 News |
|
- | Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date: Sterile Water Injections for Relieving Ureterolithiasis Pain (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=0, Withdrawn, Sponsor: University of Sk
N=90 --> 0 | Trial completion date: Dec 2017 --> Dec 2022 | Active, not recruiting --> Withdrawn | Trial primary completion date: Dec 2017 --> Dec 2022
- celecoxib oral / Generic mfg.
Enrollment change, Trial withdrawal: Celecoxib (Celebrex) in the Management of Acute Renal Colic (clinicaltrials.gov) - Jan 24, 2017
P4, N=0, Withdrawn, Sponsor: University of Minnesota - Clinical and Translational Science Institute
N=90 --> 0 | Trial completion date: Dec 2017 --> Dec 2022 | Active, not recruiting --> Withdrawn | Trial primary completion date: Dec 2017 --> Dec 2022 N=57 --> 0 | Terminated --> Withdrawn
- Trial primary completion date: Sterile Water Injections for Relieving Ureterolithiasis Pain (clinicaltrials.gov) - Jan 24, 2017
P=N/A, N=90, Active, not recruiting, Sponsor: University of Sk
N=57 --> 0 | Terminated --> Withdrawn Trial primary completion date: Jun 2016 --> Dec 2017
- alfuzosin hydrochloride / Generic mfg.
Enrollment change, Trial withdrawal: Use of Alfuzosin in Stone Treatment With ESWL (clinicaltrials.gov) - Oct 21, 2016
P3, N=0, Withdrawn, Sponsor: Singapore General Hospital
Trial primary completion date: Jun 2016 --> Dec 2017 N=200 --> 0 | Recruiting --> Withdrawn
- tamsulosin / Generic mfg.
Enrollment change: The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients (clinicaltrials.gov) - Oct 12, 2016
P=N/A, N=127, Completed, Sponsor: Robert Swor
N=200 --> 0 | Recruiting --> Withdrawn N=378 --> 127
- Enrollment closed: Sterile Water Injections for Relieving Ureterolithiasis Pain (clinicaltrials.gov) - May 13, 2016
P=N/A, N=90, Active, not recruiting, Sponsor: University of Sk
N=378 --> 127 Not yet recruiting --> Active, not recruiting
- Trial completion: Use of the PercSys MicroStent Device to Alleviate Ureteral Stone Symptoms and Hydronephrosis (clinicaltrials.gov) - Dec 14, 2015
P=N/A, N=9, Completed, Sponsor: University of British Columbia
Not yet recruiting --> Active, not recruiting Active, not recruiting --> Completed
- ||||||| Zaichang (naftopidil) / Simcere
Trial completion: Medical Expulsive Therapy for Ureter Stone Using Naftopidil (clinicaltrials.gov) - Aug 14, 2015
P3, N=150, Completed, Sponsor: Seoul National University Hospital
Active, not recruiting --> Completed Active, not recruiting --> Completed
- alfuzosin hydrochloride / Generic mfg.
Enrollment change, Trial withdrawal: A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney Stones (clinicaltrials.gov) - Aug 12, 2015
P=N/A, N=0, Withdrawn, Sponsor: St. Michael's Hospital, Toronto
Active, not recruiting --> Completed N=200 --> 0 | Terminated --> Withdrawn
- ||||| Zaichang (naftopidil) / Simcere
Enrollment closed: Medical Expulsive Therapy for Ureter Stone Using Naftopidil (clinicaltrials.gov) - Jul 21, 2015
P3, N=150, Active, not recruiting, Sponsor: Seoul National University Hospital
N=200 --> 0 | Terminated --> Withdrawn Recruiting --> Active, not recruiting
- Trial completion, Enrollment change, Trial primary completion date: Evaluating Ureteral Length Using Computed Tomography (CT) (clinicaltrials.gov) - Apr 30, 2015
P=N/A, N=53, Completed, Sponsor: Carmel Medical Center
Recruiting --> Active, not recruiting Recruiting --> Completed | N=100 --> 53 | Trial primary completion date: Feb 2014 --> Mar 2015
- |||| Zaichang (naftopidil) / Simcere
Trial primary completion date: Medical Expulsive Therapy for Ureter Stone Using Naftopidil (clinicaltrials.gov) - Apr 28, 2015
P3, N=150, Recruiting, Sponsor: Seoul National University Hospital
Recruiting --> Completed | N=100 --> 53 | Trial primary completion date: Feb 2014 --> Mar 2015 Trial primary completion date: Apr 2015 --> Jul 2015
- Enrollment closed, Trial primary completion date: Use of the PercSys MicroStent Device to Alleviate Ureteral Stone Symptoms and Hydronephrosis (clinicaltrials.gov) - Mar 25, 2015
P=N/A, N=10, Active, not recruiting, Sponsor: University of British Columbia
Trial primary completion date: Apr 2015 --> Jul 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2012 --> Aug 2015
- |||| morphine sulphate / Generic mfg.
Trial completion: Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management (clinicaltrials.gov) - Mar 18, 2015
P4, N=1645, Completed, Sponsor: Hamad Medical Corporation
Recruiting --> Active, not recruiting | Trial primary completion date: Dec 2012 --> Aug 2015 Recruiting --> Completed
- Trial completion: Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach (clinicaltrials.gov) - Feb 10, 2015
P=N/A, N=50, Completed, Sponsor: Dartmouth-Hitchcock Medical Center
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, Enrollment change, Trial primary completion date: Feasibility Study of the Uriprene Stent Following Uncomplicated Ureteroscopy (clinicaltrials.gov) - Jan 15, 2015
P1, N=8, Completed, Sponsor: Adva-Tec
Active, not recruiting --> Completed Recruiting --> Completed | N=10 --> 8 | Trial primary completion date: Jul 2014 --> Dec 2014
- tamsulosin / Generic mfg.
Enrollment change: Flowmax: Effect of Tamsulosin on Stone Expulsion and Pain Resolution in ED Patients With Ureterolithiasis (clinicaltrials.gov) - Dec 19, 2014
P=N/A, N=53, Completed, Sponsor: WellSpan Health
Recruiting --> Completed | N=10 --> 8 | Trial primary completion date: Jul 2014 --> Dec 2014 N=84 --> 53
- |||||| Zaichang (naftopidil) / Simcere
Enrollment open, Trial initiation date, Trial primary completion date: Medical Expulsive Therapy for Ureter Stone Using Naftopidil (clinicaltrials.gov) - Sep 29, 2014
P3, N=150, Recruiting, Sponsor: Seoul National University Hospital
N=84 --> 53 Not yet recruiting --> Recruiting | Initiation date: Oct 2013 --> May 2014 | Trial primary completion date: Aug 2014 --> Apr 2015
- |||| morphine sulphate / Generic mfg.
Enrollment open, Enrollment change: Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management (clinicaltrials.gov) - Sep 16, 2014
P4, N=1507, Recruiting, Sponsor: Hamad Medical Corporation
Not yet recruiting --> Recruiting | Initiation date: Oct 2013 --> May 2014 | Trial primary completion date: Aug 2014 --> Apr 2015 Not yet recruiting --> Recruiting | N=573 --> 1507
- Trial initiation date, Trial primary completion date: Sterile Water Injections for Relieving Ureterolithiasis Pain (clinicaltrials.gov) - Aug 8, 2014
P=N/A, N=90, Not yet recruiting, Sponsor: University of Sk
Not yet recruiting --> Recruiting | N=573 --> 1507 Initiation date: Nov 2010 --> Aug 2015 | Trial primary completion date: Jun 2012 --> Jun 2016
- ||||| morphine sulphate / Generic mfg.
New P4 trial: Efficacy Study of Different Analgesic Options in Kidney Stone Pain Management (clinicaltrials.gov) - Jul 12, 2014
P4, N=573, Not yet recruiting, Sponsor: Hamad Medical Corporation
- Enrollment open: Feasibility Study of the Uriprene Stent Following Uncomplicated Ureteroscopy (clinicaltrials.gov) - Mar 6, 2014
P1, N=10, Recruiting, Sponsor: Adva-Tec
Initiation date: Nov 2010 --> Aug 2015 | Trial primary completion date: Jun 2012 --> Jun 2016 Not yet recruiting --> Recruiting
- Clinical: Ureteral Stents Versus Percutaneous Nephrostomy for Initial Urinary Drainage (clinicaltrials.gov) - Feb 3, 2014
P=N/A, N=90, Completed, Sponsor: Cairo University
- New P1 trial: Feasibility Study of the Uriprene Stent Following Uncomplicated Ureteroscopy (clinicaltrials.gov) - Jan 8, 2014
P1, N=10, Recruiting, Sponsor: Adva-Tec
- |||| silodosin / Generic mfg.
Trial completion: Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones (clinicaltrials.gov) - Nov 17, 2013
P4, N=114, Completed, Sponsor: JW Pharmaceutical
Not yet recruiting --> Recruiting Enrolling by invitation --> Completed
- | celecoxib oral / Generic mfg.
Trial termination: Celecoxib (Celebrex) in the Management of Acute Renal Colic (clinicaltrials.gov) - Nov 4, 2013
P4, N=57, Terminated, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Enrolling by invitation --> Completed Completed --> Terminated; PI is no longer at the University of Minnesota
- |||| silodosin / Generic mfg.
Trial completion: A Dose-finding Study of Silodosin in Patients With Urinary Calculi (clinicaltrials.gov) - Oct 28, 2013
P2, N=300, Completed, Sponsor: Kissei Pharmaceutical Co., Ltd.
Completed --> Terminated; PI is no longer at the University of Minnesota Recruiting --> Completed
- |||||||||| Zaichang (naftopidil) / Simcere
New P3 trial: Medical Expulsive Therapy for Ureter Stone Using Naftopidil (clinicaltrials.gov) - Sep 23, 2013
P3, N=150, Not yet recruiting, Sponsor: Seoul National University Hospital
- Enrollment closed: Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach (clinicaltrials.gov) - Sep 18, 2013
P=N/A, N=50, Active, not recruiting, Sponsor: Dartmouth-Hitchcock Medical Center
Recruiting --> Completed Recruiting --> Active, not recruiting
- |||| silodosin / Generic mfg.
Trial completion: Study of Silodosin to Facilitate Passage of Urinary Stones (clinicaltrials.gov) - Aug 6, 2013
P2, N=240, Completed, Sponsor: Watson Pharmaceuticals
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- tamsulosin / Generic mfg.
Trial completion: The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients (clinicaltrials.gov) - Sep 30, 2012
P=N/A, N=378, Completed, Sponsor: William Beaumont Hospitals
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Enrollment open: Use of the PercSys MicroStent Device to Alleviate Ureteral Stone Symptoms and Hydronephrosis (clinicaltrials.gov) - Aug 12, 2012
P=N/A, N=10, Recruiting, Sponsor: University of British Columbia
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| silodosin / Generic mfg.
New P2 trial: A Dose-finding Study of Silodosin in Patients With Urinary Calculi (clinicaltrials.gov) - Feb 23, 2012
P2, N=300, Completed, Sponsor: Kissei Pharmaceutical Co., Ltd.
- ||||| silodosin / Generic mfg.
New P4 trial: Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones (clinicaltrials.gov) - Feb 13, 2012
P4, N=114, Completed, Sponsor: JW Pharmaceutical